Ease Concerns About Cancer Risk With BP Meds

January 2019

Questions are cropping up about whether blood pressure meds increase cancer risk...because of a laundry list of recalls and media reports.

Contamination with a probable carcinogen is leading to ongoing recalls with valsartan, irbesartan, losartan, and some combo products.

Now patients are also hearing that some BP meds themselves are linked to cancer...NOT because of a contaminant. Debunk these concerns.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote